Stockreport

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation
PDF Cost of Revenues (Q3 2024): $272,000 compared to $278,000 in Q3 2023. Gross Loss (Q3 2024): $268,000 compared to $235,000 in Q3 2023. Operating Expenses (Q3 2024): [Read more]